Overview Performance Dividends Peer Group Options

(MPLN) MultiPlan - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US62548M1009

MPLN: Data, Analytics, Cost, Management, Network, Integrity, Payment

MultiPlan Corporation (NYSE: MPLN) provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company leverages advanced algorithms and data-driven insights to identify and address overcharges in medical claims, negotiate reimbursements, and optimize payment processes. Its network-based services include contracted discounts with healthcare providers and outsourced network development and management. Additionally, MultiPlan offers payment and revenue integrity services that identify and correct improper charges, as well as solutions to recover underpaid premium dollars. The companys data and decision science services utilize modern data science methods to deliver descriptive, predictive, and prescriptive analytics, supporting optimized benefit plan design, improved clinical outcomes, and reduced healthcare costs. MultiPlan serves a diverse range of clients, including national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other entities involved in the claim adjudication process. Founded in 1980, MultiPlan Corporation is headquartered in New York, New York.

MultiPlan Corporations solutions are designed to enhance efficiency and accuracy in healthcare payments and cost management. By combining advanced analytics with deep industry expertise, the company helps its clients navigate the complexities of healthcare reimbursement and cost containment. Its services are tailored to address the evolving needs of the healthcare industry, ensuring that clients can maintain financial integrity and operational efficiency in an increasingly complex environment.

Ticker Symbol: MPLN Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Health Care Equipment Based on and , here is a 3-month forecast for MultiPlan Corporation (NYSE: MPLN): - Technical Outlook: The stock is currently trading at $20.99, below its 20-day SMA of $24.24 but above its 50-day SMA of $17.64. The 200-day SMA of $13.69 indicates a long-term uptrend, but the recent price action suggests short-term weakness. The ATR of $2.69 indicates moderate volatility, with potential price swings of 5-10% over the next three months. - Fundamental Outlook: With a market cap of $374.98M and a P/S ratio of 0.40, the stock appears undervalued relative to its peers. However, the P/B ratio of 4.53 suggests that the stock may be overvalued relative to its book value. The lack of P/E and forward P/E data makes it difficult to assess earnings expectations, but the companys focus on cost containment and payment integrity could drive future growth. - Expected Price Range: Over the next three months, MPLN is expected to trade between $18.00 and $24.00, with potential resistance at the 20-day SMA of $24.24 and support at the 50-day SMA of $17.64. Investors should monitor volume trends, as the average 20-day volume of 193,221 shares indicates moderate liquidity. - Key Drivers: The companys ability to maintain its market position in the healthcare cost management sector, coupled with its focus on data-driven solutions, will be critical to its performance. Additionally, any changes in the regulatory environment or shifts in healthcare payment dynamics could impact the stocks trajectory.

Additional Sources for MPLN Stock

News: Wall Street Journal Benzinga Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MPLN Stock Overview

Market Cap in USD 375m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Equipment
IPO / Inception 2020-04-03

MPLN Stock Ratings

Growth 5y -89.2%
Fundamental -17.5%
Dividend 0.0%
Rel. Strength Industry -38.1
Analysts 3.33/5
Fair Price Momentum 15.03 USD
Fair Price DCF -

MPLN Dividends

No Dividends Paid

MPLN Growth Ratios

Growth Correlation 3m 92.3%
Growth Correlation 12m -54.6%
Growth Correlation 5y -95.9%
CAGR 5y -44.80%
CAGR/Max DD 5y -0.45
Sharpe Ratio 12m -1.22
Alpha -66.35
Beta 2.23
Volatility 239.30%
Current Volume 136.4k
Average Volume 20d 168.5k
What is the price of MPLN stocks?
As of March 14, 2025, the stock is trading at USD 20.99 with a total of 136,363 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -19.52%, over three months by +191.12% and over the past year by -36.01%.
Is MultiPlan a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, MultiPlan is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MPLN as of March 2025 is 15.03. This means that MPLN is currently overvalued and has a potential downside of -28.39%.
Is MPLN a buy, sell or hold?
MultiPlan has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold MPLN.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MPLN stock price target?
According to ValueRays Forecast Model, MPLN MultiPlan will be worth about 16.2 in March 2026. The stock is currently trading at 20.99. This means that the stock has a potential downside of -22.68%.
Issuer Forecast Upside
Wallstreet Target Price 10 -52.4%
Analysts Target Price 11.3 -46.4%
ValueRay Target Price 16.2 -22.7%